Organ Transplant Diagnostics Market: A Study of Key Players, Trends, and Forecast to 2028


According to the TechSci Research report titled “Global Organ Transplant Diagnostics Market – Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028,” the global organ transplant diagnostics market is expected to experience a high Compound Annual Growth Rate (CAGR) during the forecast period. This growth can be attributed to the continuous improvement in the healthcare infrastructure of various countries.

The increase in donors of vital organs worldwide is driving the expansion of the global organ transplant diagnostics market in the forecast period. Among various organs, kidney and liver donations are the most prevalent. The Global Observatory on Donation and Transplantation (GODT) reported in 2020 that the top five countries with the highest number of deceased organ donors per million population were Spain, Croatia, Belgium, France, and the United States of America. Additionally, data presented by Statista on The Global Gulf in Organ Donation Rates in 2022 revealed that Spain and the United States of America accounted for 38% of donors per million population globally, followed by Portugal with 24.8% donors, France with 23.2% donors, and the UK with 18.4% donors, among others.

Diagnostic tests are mandatory to be performed on both organ donors and recipients before the transplant procedure, contributing to the growth of the global organ transplant diagnostics market during the forecast period. Remarkable advancements in transplant technology have led to an increased success rate of organ transplants. One notable development is the utilization of next-generation sequencing (NGS) technology in organ transplant diagnostics. NGS enables the analysis of the genetic makeup of both the donor and the recipient, enabling better organ matching and reduced risk of rejection. Furthermore, NGS can detect infections and monitor the immune system, aiding in the detection and management of post-transplant complications. Non-invasive diagnostic tools like liquid biopsies and breath tests are another crucial advancement. These tests can identify organ rejection and other complications without invasive procedures, thereby reducing the risk of complications and improving patient outcomes.

Moreover, the adoption of several advanced technologies by healthcare professionals to enhance the efficiency of organ transplant procedures is expected to boost the global organ transplant diagnostics market during the forecast period. Additionally, the organization of various campaigns and health awareness programs has contributed to growing awareness among people about organ transplantations, further driving market growth. The presence of highly qualified healthcare professionals and well-equipped hospitals and medical centers worldwide is a significant factor fueling the market’s expansion. Furthermore, improvements in medical facilities and healthcare infrastructure globally are projected to drive the demand for organ transplant diagnostics during the forecast period.

However, certain challenges might impede market growth in the coming years, including the high procedural cost of NGS and PCR-based diagnostic assays, limited knowledge dissemination, and reluctance toward organ transplants among some individuals.

Browse over 25 market data Figures and spread through 91 Pages and an in-depth TOC on “Global Organ Transplant Diagnostics Market” –

The global organ transplant diagnostics market is segmented based on offering, application, transplant type, technology, end user, and region.

Based on end user, the market is further divided into hospitals and transplant centers, academic and research institutions, reference laboratories, and other end users. Hospitals and transplants centers are likely to dominate the market during the forecast period. This can be ascribed to a wide range of expertise provided by the hospitals in pathology and laboratory diagnostics for conducting screening in pre-transplant and post-transplant surgeries.

Some of the major companies operating in the global organ transplant diagnostics market include:

  • Abbott Laboratories
  • bioMérieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Eurobio Scientific (Genome Diagnostics B.V.)
  • Hoffmann-La Roche Ltd.
  • Omixon Inc.
  • Thermo Fisher Scientific Inc.
  • Quest Diagnostics Incorporated
  • CareDx, Inc.
  • Core Diagnostics Private Limited

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“Certain regions such as Asia Pacific are expected to dominate the global organ transplant diagnostics market during the forecast period due to growing number of organ transplantations in various developing countries such as United States. Increase in support provided by the government to improve healthcare infrastructure of individual country by providing funding to the companies making innovation in diagnostic facilities are further expected to register a lucrative growth of the global organ transplant diagnostics market during the forecast period,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

Organ Transplant Diagnostics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 – By Offering (Kits and Assays, Consumables, and Services), By Application (Donor Testing (Pre-transplantation testing (Histocompatibility Testing, Blood Profiling Testing, and Other Testing), Post-transplantation testing (Post-Infection Testing, Risk of Disorder Testing, and Other Testing)), Recipient Testing (Pre-transplantation testing (Histocompatibility Testing, Blood Profiling Testing, and Other Testing), Post-transplantation Testing (Post-Infection Testing, Risk of Disorder Testing, and Other Testing)), By Transplant Type (Solid Organ Transplant (Kidney, Liver, Lung, Pancreas, and Other Organs Transplant), Stem Cell Transplant), By Technology (Molecular Technologies (PCR, Sanger Sequencing, Next-Generation Sequencing (NGS), Other Molecular Technologies), Non-molecular Technologies (Serology, Flow Cytometry), Other Technologies), By End User (Hospitals and Transplant Centers, Academic and Research Institutions, Reference Laboratories, and Other End Users), and By Region and Competition”, has evaluated the future growth potential of the global organ transplant diagnostics market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the global organ transplant diagnostics market.

Download Free Sample Report –

About TechSci Research:

TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.


Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]


Leave a Comment